Amaresh Vydyanathan, MD
Interventional Pain Medicine · Bloomington, ILNPI 1336319094
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,014 of the $6,396 with a category attached, or 78.4%. 16 manufacturers reported payments, led by Boston Scientific at 50.1% of the total.
Across 130 payments — averaging $49.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- Nevro Corp.$848
- Edwards Lifesciences$700
- Medtronic$569
- SPR Therapeutics, Inc$218
- Vertex$211
- plus $646 from 10 others
What the payments were for
- Consulting fees$3005%
- Speaking & faculty fees$4006%
- Travel & lodging$68211%
- Food & beverage$5,01478%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 67 | $3,204 |
| Nevro Corp. | 18 | $848 |
| Edwards Lifesciences | 2 | $700 |
| Medtronic(2 entities) | 21 | $569 |
| SPR Therapeutics, Inc | 3 | $218 |
| Vertex | 4 | $211 |
| AbbVie | 4 | $127 |
| Globus Medical | 1 | $116 |
| Cumberland Pharmaceuticals, Inc. | 2 | $102 |
| Heron Therapeutics, Inc. | 1 | $90 |
| Trice Medical, Inc. | 1 | $70 |
| Averitas Pharma Inc. | 1 | $47 |
| Avanos Medical | 2 | $42 |
| Pacira Pharmaceuticals Incorporated | 1 | $21 |
| Saluda Medical Americas, Inc. | 1 | $16 |
| Stimwave Technologies Incorporated | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,396 in reported general payments places this provider in the 65th percentile of 93 interventional pain medicine providers in Illinois.
See all interventional pain medicine providers in Illinois →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium ErDiclofenac Sodium | 103 | $7,864 |
| Naproxen Sodium | 22 | $2,368 |
| Diclofenac Sodium | 67 | $1,093 |
| Doxepin Hcl | 12 | $1,024 |
| Pregabalin | 40 | $999 |
| Lidocaine | 11 | $717 |
| Gabapentin | 90 | $695 |
| Celecoxib | 36 | $369 |
| Duloxetine Hcl | 36 | $289 |
| Tizanidine Hcl | 42 | $134 |
| Nortriptyline Hcl | 22 | $97 |
| Meloxicam | 37 | $96 |
| Ibuprofen | 12 | $75 |
| Cyclobenzaprine Hcl | 21 | $28 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Bloomington
- Ramsin BenyaminBloomington$32K
- Benjamin TaimoorazyBloomington$4K
- Alexander FeoktistovNorthfield$922K
- Timothy LubenowChicago$556K
- Sandeep AminChicago$430K
- Matthew JaycoxChicago$123K
- Hong VoChicago$91K
- Asokumar BuvanendranChicago$52K
- Adam YoungChicago$29K
- Salman SagarwalaChicago$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.